Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre and Prospective Trial to Evaluate the Effects on Multiple Sclerosis Related Fatigue During Treatment With Tysabri in Patients With Relapsing Remitting Multiple Sclerosis Over the Course of 12 Months

NCT00884481 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00884481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00884481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre and Prospective Trial to Evaluate the Effects on Multiple Sclerosis Related Fatigue During Treatment With Tysabri in Patients With Relapsing Remitting Multiple Sclerosis Over the Course of 12 Months
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
March 23, 2009
Completion date
June 30, 2011
Enrollment
195 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, relapsing-remitting multiple sclerosis